INMUNE BIO INC. Increase Decrease In Operating Lease Liability
INMUNE BIO INC. (INMB) reported Increase Decrease In Operating Lease Liability of $38.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- INMUNE BIO INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $58.00K.
- INMUNE BIO INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$20.00K.
- INMUNE BIO INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was $104.00K.
- INMUNE BIO INC. increase decrease in operating lease liability for the quarter ending 2025-03-31 was -$8.00K.
- INMUNE BIO INC. increase decrease in operating lease liability for fiscal 2025 was $43.00K.
- INMUNE BIO INC. increase decrease in operating lease liability for fiscal 2024 was -$25.00K.
- INMUNE BIO INC. increase decrease in operating lease liability for fiscal 2023 was -$4.00K.
- INMUNE BIO INC. increase decrease in operating lease liability for fiscal 2022 was -$33.00K, a 171.74% decline from fiscal 2021.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $38.00K 10-Q · filed 2026-08-06 | $142.00K derived: sum of 3 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$20.00K 10-Q · filed 2026-05-07 | $84.00K derived: sum of 2 quarters · filed 2026-05-07 | ||
| 2025-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $43.00K 10-K · filed 2026-03-30 | ||
| 2025-09-30 | -$61.00K 10-Q · filed 2025-10-30 | |||
| 2025-03-31 | -$8.00K 10-Q · filed 2026-05-07 | -$15.00K derived: sum of 2 quarters · filed 2026-05-07 | -$20.00K derived: sum of 3 quarters · filed 2026-05-07 | -$27.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$12.00K derived: sum of 2 quarters · filed 2026-03-30 | -$19.00K derived: sum of 3 quarters · filed 2026-03-30 | -$25.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$12.00K derived: sum of 2 quarters · filed 2025-10-30 | -$18.00K 10-Q · filed 2025-10-30 | -$8.00K derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$13.00K 10-Q · filed 2025-08-07 | -$3.00K derived: sum of 3 quarters · filed 2025-08-07 | -$7.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$6.00K 10-Q · filed 2025-05-08 | $4.00K derived: sum of 2 quarters · filed 2025-05-08 | $0.00 derived: sum of 3 quarters · filed 2025-05-08 | -$23.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $6.00K derived: sum of 2 quarters · filed 2025-03-27 | -$17.00K derived: sum of 3 quarters · filed 2025-03-27 | -$4.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$27.00K derived: sum of 2 quarters · filed 2024-10-31 | -$14.00K 10-Q · filed 2024-10-31 | -$130.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$10.00K 10-Q · filed 2024-08-01 | -$126.00K derived: sum of 3 quarters · filed 2024-08-01 | -$101.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $13.00K 10-Q · filed 2024-05-09 | -$103.00K derived: sum of 2 quarters · filed 2024-05-09 | -$78.00K derived: sum of 3 quarters · filed 2024-05-09 | -$55.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$91.00K derived: sum of 2 quarters · filed 2024-03-28 | -$68.00K derived: sum of 3 quarters · filed 2024-03-28 | -$33.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $48.00K derived: sum of 2 quarters · filed 2023-11-01 | $83.00K 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $58.00K 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | $35.00K 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | $46.00K 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |